Director, HTA, Value & Evidence (HV&E), Internal Medicine Early Pipeline
This role involves leading the development and execution of global evidence generation strategies to support patient access to obesity and non-obesity products in Pfizer's early pipeline. The Director will work closely with cross-functional teams to design and conduct HEOR studies, economic models, and real-world data studies, ensuring that the evidence aligns with global market access needs and regulatory requirements.